The ChristianaCare Gene Editing Institute accelerates breakthroughs in CRISPR gene editing to improve human health.
Driven by its urgent mission to develop disease-conquering therapies, the Gene Editing Institute both accelerates the science and hones the precision of gene editing. The scientific discoveries of the Institute have led to the development of a highly innovative lung cancer therapy to test CRISPR gene editing in solid tumors for the first time.
The Gene Editing Institute supports researchers with the tools to do their work more quickly and precisely and seeks ways to make these tools safe and effective for knocking out cancer or genetic diseases like sickle cell. The team developed the first CRISPR tool to repair DNA outside the human cell.